Top compounds associated with response to DHX16


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA birinapant CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA ML006 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV